Atlas Trials

Trial Evaluating Induction Therapy With Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy With Azacitidine

Clinical trial NCT01180322 · COMPLETED

Trial details

NCT number
NCT01180322
Sponsor
University of Ulm
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Myeloid Leukemia (AML)
Start date
2010-11-01
Primary completion
2012-06-01
Enrollment
277

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.